Quarterly Earnings

Smart scooter giant Niu Technologies posted record annual sales driven by China, but a sharp Q4 drop, especially abroad, clouds its global outlook.

International Petroleum Corp. is ahead of schedule and on budget at its massive Blackrod oil sands project, signaling a major win for Canadian energy.

RxSight will showcase its unique post-surgery adjustable lens at J.P. Morgan, facing investor questions on growth in a competitive ophthalmology market.

Tesla's Q4 report shows a complex picture. Vehicle deliveries fell short, but record-breaking growth in the energy division hints at a major strategic shift.

Principal Financial is set to unveil its 2026 forecast. Investors weigh strong 2025 results against analyst caution and shifting economic tides.

Investors eye Hexcel's Q4 2025 results for signs of an aerospace rebound, strategic shifts under new leadership, and the future of advanced composites.

RPM International's 52nd straight year of dividend hikes cements its 'Dividend King' status. We look at the strategy behind this rare achievement.

Shipping giant Costamare Inc. reaffirms its financial strength with consistent shareholder payouts, backed by a strong market and strategic growth.

With a 79% drop in net loss and a fourth straight growth quarter, supplement maker Vitality Products Inc. bets on new hires to conquer online and retail.

As Wesdome Gold Mines targets mid-tier status, the appointment of financial expert Faheem Tejani signals a strategic move to bolster financial oversight.

With strong financials and new clinical data, medical device leader Penumbra is set to detail its growth strategy at healthcare's top investor event.

MENA's streaming leader Anghami doubles its subscribers after its OSN+ merger, but a $37M loss raises questions about its high-stakes growth strategy.

After a year of major acquisitions and AI-driven innovation, all eyes are on Labcorp's strategic vision for 2026 at the J.P. Morgan Healthcare Conference.

Treace Medical heads to the J.P. Morgan conference to showcase its surgical tech, facing tough questions on growth amid competition and market shifts.

INVO Fertility realigns its top brass, positioning a deal-making veteran to lead an aggressive clinic acquisition strategy in a booming market.

Investors await Polaris's Q4 results on Jan. 27, seeking clarity on market share gains, tariff impacts, and the future of its Indian Motorcycle brand.

As Axos sets to reveal its Q2 results, investors weigh strong growth forecasts against mounting concerns over margin pressure and a shifting economy.

Berlin-based Sportstech suspends acquisition talks with Nasdaq's TRNR, derailing U.S. plans and sparking a public dispute over the failed deal.

Daily Journal Corp's revenue soars 25% on the back of its tech arm, revealing a successful pivot and a unique model blending software and investments.

After selling its Oklahoma assets, Amplify Energy has eliminated its debt and is now focusing its capital on high-potential Beta and Bairoil fields.